The Effect of Oral Oxytocin and Atosiban on Top-down Attention ( OTAtosiban )

ConditionHealthy Adult Male

Trial statusRecruiting

Trial phaseEarly Phase 1

Trial typeInterventional

Biological sexMale

Age18-35

SponsorUniversity of Electronic Science and Technology of China

About this trial

The main aim of the present study is to investigate whether orally (lingual spray) administered oxytocin influences human top-down attention via oxytocin receptors and whether its effects are dose- and task-dependent.

Eligibility criteria

Qualifiers

Healthy male subjects without past or current psychiatric or neurological disorders

Disqualifiers

History of or current neurological/psychiatric disorders;

Use of psychotropic medications (including nicotine)

Visual impairments

Trial design

Treatments tested in this trial

Oxytocin lower does (24IU)
Oxytocin higher does (48IU)
Atosiban
Placebo

Treatment groups

250 Participants

are divided into 5 treatment groups

Sponsors and collaborators

University of Electronic Science and Technology of China

Lead sponsor

Source ClinicalTrials.gov